Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca PLC Regulatory Filings 2015

Nov 2, 2015

5229_rns_2015-11-02_2f13bbed-aa49-4438-a0a2-2320d597eb99.html

Regulatory Filings

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1883E

AstraZeneca PLC

02 November 2015

Transparency Directive

Voting Rights and Capital

The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. On 31 October 2015 the issued share capital of AstraZeneca PLC with voting rights is 1,263,837,596 ordinary shares of US$0.25.  No shares are held in Treasury.  Therefore, the total number of voting rights in AstraZeneca PLC is 1,263,837,596.

The above figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, AstraZeneca PLC under the UK Financial Conduct Authority's Disclosure and Transparency Rules.

A C N Kemp

Company Secretary

2 November 2015

This information is provided by RNS

The company news service from the London Stock Exchange

END

TVRLLFLLLVLFIIE